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Abstract
Objective—To learn the attitudes and concerns of the local community on participating in
research, infant feeding practices, and maternal nutrition in order to inform the design of a clinical
trial in Lilongwe, Malawi on the safety and efficacy of antiretroviral and nutrition interventions to
reduce postnatal transmission of HIV.
Design—Formative research methods were used, including semi-structured interviews, focus
group discussions, home observations, and taste trials. Data were collected, analyzed, and
incorporated into the protocol within three months.
Results—Participants were supportive of the clinical trial, although their overall understanding
of research was limited. Mothers agreed that infants’ blood could be drawn by venipuncture, yet
concern was raised about the amount of blood proposed to be collected from both infants and
mothers. Data demonstrated that rapid breastfeeding cessation would be difficult and malnutrition
could be a risk if infants were weaned early. Mothers selected a maternal supplement suitable for
use in the clinical trial.
Conclusions—The protocol was rapidly modified to achieve cultural acceptability while
maintaining study objectives. Without the formative research, several significant areas would have
been undetected and may have jeopardized the implementation of the trial. Additional research
was carried out to develop a meaningful informed consent process, the amount of blood collected
was reduced to acceptable levels, and the protocol was modified to reduce the risk of malnutrition.
Researchers who conduct clinical trials are encouraged to incorporate formative research into their
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protocol design to ensure participant understanding of the research, to safeguard participants, and
to increase feasibility and acceptance of the clinical research in the community.
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Introduction
Overview
Formative research is the systematic collection of information to inform an intervention,
research, or policy. While formative research has been used to inform clinical trial protocols
[1,2], the importance of such research and examples of study designs are not often published
in the scientific literature. In this paper, we describe a formative research study involving
semi-structured interviews, focus group discussions, home observations, and trials of
nutrition supplements and practices to inform a clinical trial protocol on interventions to
improve maternal nutrition and reduce postnatal transmission of HIV. Data collection and
preliminary analysis were completed within three months and findings were immediately
incorporated into the protocol. Comprehensive analyses followed to inform data collection
instruments and counseling materials. Through examples, we will demonstrate the value of
such research for improving the design of clinical trials.
Background
The Breastfeeding, Antiretroviral, and Nutrition (BAN) study—The BAN study is
an un-blinded clinical trial in Lilongwe, Malawi, on the safety and efficacy of antiretroviral
and nutritional interventions to reduce mother-to-child transmission of HIV during
breastfeeding [3, 4]. The objectives are to determine the benefit of nutritional
supplementation given to mothers during breastfeeding, the benefit and safety of
antiretroviral medications given either to infants or to their mothers to prevent HIV
transmission during breastfeeding, and the feasibility of exclusive breastfeeding followed by
early, rapid breastfeeding cessation to prevent late postnatal HIV transmission. The study
has a randomized 2-by-3 factorial design where mothers receive or do not receive a daily
nutritional supplement, and mothers, infants, or neither receives daily antiretroviral
prophylaxis for 24 to 28 weeks during the breastfeeding period (Figure 1). The trial is
conducted in an urban area hospital setting and participants are individually randomized as
individual participants are unlikely to know each other. Healthy breastfeeding mothers with
a CD4 count >200 cells/μL and hemoglobin ≥ 7 g/dL and their HIV-negative newborns are
eligible to enroll. All mothers receive infant feeding counseling and are advised to stop
breastfeeding completely between 24 to 28 weeks post delivery. Enrollment began in March
2004.
Infant feeding and nutrition considerations—Previous research has suggested that
mother-to-child transmission of HIV during breastfeeding is higher when mothers practice
mixed feeding (providing solids and liquids in addition to breast milk) compared to
exclusive breastfeeding [5, 6], and the risk of HIV transmission continues as long as the
mother breastfeeds [7, 8]. While early cessation of breastfeeding reduces the risk of HIV
transmission, it may increase the likelihood of malnutrition and malnutrition-associated
mortality if nutritionally adequate replacement foods are not available and regularly
consumed [9]. Mothers in many parts of Africa, however, lack the resources necessary to
purchase replacement foods regularly, face stigma and discrimination if they choose not to
breastfeed, and have limited access to clean water that is needed to prepare replacement
foods safely. For these reasons, WHO currently recommends exclusive breastfeeding for the
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first months of life and discontinuation of breastfeeding as soon as replacement feeding is
acceptable, feasible, affordable, sustainable and safe for all HIV-positive mothers who chose
to breastfeed [10].
In sub-Saharan Africa, neither exclusive breastfeeding nor early breastfeeding cessation are
commonly practiced [11] and the non-HIV risks associated with early cessation are not
known. The median duration of exclusive breastfeeding among mothers in Malawi is 2
months, and 54% of infants continue to breastfeed at 24 months [12]. While some mothers
may be familiar with rapid breastfeeding cessation for reasons such as pregnancy or illness,
rarely, if ever, does it occur before 28 weeks [13]. Malnutrition rates are unacceptably high
in Malawi, with 49% of children less than 5 years suffering from stunting (low height-for-
age) [12]. High rates of malnutrition are due in part to annual food shortages that sometimes
reach crisis proportions. Breast milk is a major source of infant nutrition from birth through
the first two years and locally available weaning foods are of poor nutritional quality, with
low energy and micronutrient density [14]. Thus, early breastfeeding cessation would likely
increase the likelihood of severe adverse events such as malnutrition and malnutrition-
associated mortality if nutritionally adequate replacement foods were not regularly available
and consumed [9,15].
Formative research objectives—With this background in mind, the formative research
had three primary objectives: (1) to understand local infant feeding practices and to explore
the feasibility of modifying them to prevent postnatal transmission of HIV; (2) to explore
issues related to participation in the BAN clinical trial, such as attitudes toward participation
in the study, being randomized to different interventions, and the collection of blood and
other body fluid samples; and (3) to design a nutrition supplement for breastfeeding
mothers.
The formative research was approved by the institutional review boards at the Centers for
Disease Control and Prevention and University of North Carolina at Chapel Hill, and the
National Health Science Research Committee in Malawi. All participants provided a written
informed consent.
Methods
During June and July 2002, 72 semi-structured interviews were conducted with 40 HIV-
positive mothers. Mothers participated in up to three interviews each, covering study
participation, infant feeding, and maternal nutrition issues. Semi-structured interviews were
also conducted in the homes of 35 mothers of undisclosed HIV status. Mothers participated
in three interviews each and topics included infant feeding, maternal nutrition and dietary
intake, and observation of hygiene and sanitation conditions. All mothers had infants less
than 1 year old. Data on maternal and infant dietary intakes were collected by using a
modified 24-hour recall methodology developed by Ferguson et al. [16].
Mothers visited at home also participated in trials of four different nutrition supplements to
assess their acceptability. The supplements tested included: (1) a nutritionally fortified
maize-soy blend; (2) a nutritionally fortified sweet biscuit; (3) a nutritionally fortified
unsweetened biscuit; and (4) vitamin-mineral sprinkles to mix with the staple food (maize).
Mothers were given a 2-day supply of each supplement and the follow-up interview was
scheduled within this time period to assess their experience with each product. Mothers were
counseled on how to prepare and consume each supplement and were also advised not to
share the supplement with other family members or friends.
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Additionally, 12 focus group discussions were conducted with 77 pregnant women,
grandmothers, and fathers, and 33 semi-structured interviews were conducted with health
providers, community leaders, and traditional birth attendants; a few of these interviews
were conducted prior to the primary data collection period. Details on the sample and
interview topics are provided in Table 1.
Local AIDS support organizations and nurses from health clinics identified eligible mothers.
Participants were selected from several geographic areas using non-probability, purposeful
sampling strategies [17].
Eleven experienced Malawian interviewers conducted all interviews, focus group
discussions, home observations, and taste trials. Before data collection, the interviewers
participated in a 2-week training course. Question guides were translated into the local
language, Chichewa, and back-translated into English. All interviews and focus group
discussions were audiotaped, simultaneously transcribed and translated verbatim into
English by the interviewer directly after the interviews and focus group discussions were
conducted, and then subsequently reviewed by investigators. A two-day workshop with the
formative research team was held immediately after data collection to formulate specific
recommendations for protocol modification, followed by a meeting with the clinical trial
team to discuss and incorporate protocol changes based on the research findings.
Comprehensive analyses followed for other study purposes, such as to inform behavioral-
related questions on data collection forms and to create messages for nutrition counseling.
Content analysis identified cultural, social, and behavioral themes and patterns related to the
research topics following the analytical methods described by Miles and Huberman [18]. We
created deductive codes based on research questions and data-derived codes for key
concepts that emerged from the data. Transcripts were coded by multiple investigators using
QSR NUD*IST Vivo software. Each code was then examined in detail for sub-themes and
patterns across the interviews, and the most essential points were identified. Here we present
data from focus group discussions and interviews with HIV-positive mothers and mothers of




Twenty-seven HIV-positive mothers and 35 mothers of undisclosed status were interviewed
about infant feeding practices and nutrition; dietary recalls were collected for infants of
mothers of undisclosed status. Although all of the 27 HIV-positive mothers interviewed
were currently breastfeeding their infants, only 50% knew about exclusive breastfeeding and
even fewer mothers had ever practiced it. Approximately 85% of the HIV-positive mothers
said they gave water or thin porridge to their infants before the fourth month, and 60%of the
17 mothers of undisclosed HIV status who had an infant less than 6 months old had already
introduced foods and/or liquids other than breast milk into their infants’ diets by the fourth
month. One mother said, “Traditionally, we are told that if a child cries, it’s a sign of
hunger. Because my baby was crying, I thought breast milk was not adequate, so I started
giving him water at 3 months.”
All HIV-positive mothers acknowledged the nutritional importance of breast milk, but one-
half asserted that infants less than 6 months old “cannot grow properly with breast milk
only.” Several mothers also believed that mothers would need additional foods to produce
enough breast milk to breastfeed their infants exclusively for 6 months. In addition, several
commented that HIV intensifies the nutritional needs of breastfeeding mothers. One mother
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explained: “When you have the virus, there’s a need to eat different types of food. For a
breastfeeding mother, she can be sharing her vitamins with the baby, thus paving the way for
the virus to multiply in the mother.”
Contrary to the cultural norm of breastfeeding infants through the second year of life, HIV-
positive mothers said they would be willing to discontinue breastfeeding at 6 months to
reduce transmission of HIV, but most expressed concern about their ability to purchase
replacement foods. One mother said, “Many mothers will not manage to get extra food for
the baby, and, as a result the baby may be malnourished.” Due to their inability to afford
additional foods for their infants, several HIV-positive mothers were certain that infants
would become malnourished if they were no longer given breast milk. One mother said,
“The baby will suffer and start losing weight because breast milk is taken away.” As a
result, many mothers believed that a mother’s ability to stop breastfeeding at 6 months of
age depended on the availability of replacement foods. This finding was also mentioned
repeatedly in the focus group discussions. As explained by a pregnant woman: “It depends if
adequate amounts of other foods are available. If food is available, the baby will be all right.
But, if food is not available, the baby can become malnourished.”
Concerns about the possibility of malnutrition are well substantiated. Findings from the
modified 24-hour dietary recalls, which were conducted among infants who were
breastfeeding, indicated very low energy intakes (mean, 397 kcal/day) from foods other than
breast milk, particularly during the 6-to-8 month period after birth. Thus, complete removal
of breast milk from the diet during this period without access to adequate replacement foods
might lead to weight loss and severe malnutrition, given that the total energy requirement for
a healthy infant is about 615 kcal/per day at this age [14].
Energy intakes from foods other than breast milk were higher in infants who were 9-to-11
months old (mean, 737 kcal/day) but the quality of the diet was very poor, particularly in
terms of micronutrients. For example, the average daily iron intakes were 1.8 and 3.3 mg/
day for infants aged 6-to-8 and 9-to-11 months old, respectively. The recommended daily
intake of iron is 22 mg/day during this age period [14].
Similar to the cultural norm for weaning practices, HIV-positive mothers stressed that
infants should be weaned gradually (within a few weeks) rather than rapidly (within a few
days). Rapid cessation was perceived by many as damaging to infants and cruel, and
therefore few supported it as a cessation method for HIV-positive mothers who choose to
discontinue breastfeeding at 6 months. Focus group participants also did not support rapid
cessation of breastfeeding. One grandmother described why rapid cessation is not
acceptable: “A baby can become thin if you don’t stop breastfeeding gradually. This
happens because sometimes the baby can be refusing the other foods that are given to it.
“ One man explained, “When infants are introduced to new foods that they are not used to, it
may cause an upset stomach.” Concerns about possible stigma associated with early
breastfeeding cessation were mentioned, but this issue was not specifically linked to HIV
status.
Study participation issues
Willingness to participate and perceived benefits of research—Twenty-three
HIV-positive mothers were interviewed about study participation issues. Of these, all said
they would join the BAN study if they were eligible at the time of enrollment but their
reasons for wanting to participate demonstrated a limited understanding of the research. For
example, even though all the mothers appeared to have understood that the purpose of
providing antiretroviral drugs was to prevent infants from getting HIV during breastfeeding,
few recognized that the purpose of the research was to determine whether the drugs were
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indeed safe and efficacious for this use, an entirely different concept. As a result, most HIV-
positive mothers strongly believed that the physicians involved in the research would give
them only medicines that had already been proven safe and efficacious in preventing HIV
transmission during breastfeeding. As described by one mother, “Because the medicines
were tested, the doctors know that the medicines are helpful.” Another mother said, “These
medicines were made so that they should be given to babies to prevent the spread of HIV, so
they are not harmful.” Responses were also indicative of the strong trust HIV-positive
mothers have in doctors: “If the medicine is given by doctors, that means they know that the
medicine is helpful and can prevent the baby [from getting HIV].”
Similarly, because of their belief in the effectiveness of the medicines, responses also
reflected the faith HIV-positive mothers placed in the power of medicine. Accordingly, all
but two of the 23 HIV-positive mothers interviewed about study participation expected that
infants would obtain a therapeutic benefit from the study medicines. One mother said,
“Because the baby is receiving medications, there is no reason why the baby should get
HIV.” Another mother said, “Mothers will think that the research wants to assist them so
that their babies should grow healthy.” In addition, more than three-fourths of HIV-positive
mothers mistakenly believed that another purpose of the drugs used in the research was to
“prolong the mothers’ lives.” One mother said, “Mothers will want to take the medicine so
that they do not develop AIDS quickly.” Moreover, 30% of 23 HIV-positive mothers
interviewed suggested they might share their medicines with their husbands, who were
presumed to be HIV-positive.
Understanding of randomization—HIV-positive mothers’ understanding of the
rationale for randomization was limited. The majority did not understand the purpose of
placing study participants in different study conditions when all were HIV-infected. Limited
understanding of randomization was also found among focus group participants, as
described by a male participant:
“To me, it’s bad to put [people into] groups. Let’s say all of us here have diarrhea.
If one is given the cure for the diarrhea and others aren’t, are you going to be
happy? You cannot be happy. All of us should be given the medicine to cure the
diarrhea. The same [is true] with mothers [in this research]. All have HIV. All need
to receive the same medicine. If there are drugs to protect mothers, every mother
must be given [them].”
Some HIV-positive mothers believed allocation of participants to study conditions was
determined by the participant’s medical needs and not by chance. In response to a question
that explored the rationale for randomization of the nutrition intervention, one mother
explained, “Participants will think that they are healthy, and that’s why they are not given
the food supplements.” Yet, other mothers perceived that preferential treatment determined
who would be assigned to each study condition, as described by another mother: “Women
will be questioning why they have not received the supplements that [others] received. They
will feel that there is favoritism.” Those who understood that allocation to study conditions
was based on chance thought it was unfair that some participants would not receive
antiretroviral drugs or nutritional supplements. These findings further demonstrate the belief
of a therapeutic benefit from participation in research and illustrate the complexity of
explaining the purpose of research that uses antiretrovirals as prophylaxis against
transmission.
Acceptable amount of biological specimens—All 23 HIV-positive mothers said that
venous blood could be drawn regularly from mothers for research purposes, and 21 mothers
felt that infants’ blood could also be drawn by venipuncture. Despite their agreement,
concerns were raised. One mother said, “People will definitely be suspicious when large
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amounts of blood are drawn.” Some feared that their blood would be sold. Furthermore,
52% of 23 HIV-positive mothers interviewed indicated that the proposed amount of blood
(50 ml) to be drawn from mothers was too much, and 47% indicated that the proposed
amount from infants (15 ml) was also too much. One mother said, “The mother will despair
and think that the baby will fall sick or she will run short of blood, and she will be sick now
and then.” Focus group participants also shared these beliefs. For example, one man said,
“The mother is sick, and therefore she needs a lot of blood. It is important that only a little
amount of blood be drawn from her.” As a result, we asked participants to identify suitable
amounts of blood quantity that would be acceptable to be drawn at each study visit. Few
concerns were raised about breast milk samples from mothers and urine samples from
infants.
Maternal nutrition supplement—Twenty-two HIV-positive mothers and 35 mothers of
undisclosed status were interviewed about their nutrition in general; mothers of undisclosed
status participated in the taste trials. Data on maternal nutrition among the HIV-positive
mothers are published elsewhere [20]. Here we describe data on the maternal nutrition
supplement. Mothers preferred the maize soy blend and the sweet biscuit. Due to difficulties
in product supply, an additional taste test of a nutritionally fortified peanut butter paste was
conducted with 17 women at a later date, and this product was also found acceptable.
Although mothers were amenable to daily consumption of any of these foods, it was also
clear that supplement sharing would occur with all of the products. For example, 88% of the
17 mothers interviewed said they would consume the peanut butter-spread daily, yet 53%
shared it with their neighbors, family members, and/or children. Of those who did not share
the supplement, 38% said it would be very difficult not to share it in the future because, as
told by one mother, “[in our culture], food has to be shared, no matter how small it is.”
Another mother said, “My children are also malnourished. I would share the supplements
with them so they can also have good health.” We explored methods to reduce sharing, such
as providing a small bag of maize for the rest of the family. While many mothers presumed
that this could offset the sharing of the maternal supplement, several others believed the
maternal supplement would still be shared.
In the end, we chose to use the peanut butter spread because supply and quality of this
supplement were easiest to ensure, particularly with respect to micronutrients. Based on the
information provided by mothers, the supplement was named “Nutrition for Breastfeeding
Mothers,” to minimize any stigma associated with its use in the context of the study and to
possibly reduce sharing. To further offset supplement sharing, all families are provided with
a small bag of maize from the study. Food is also provided to participants from the World
Food Programme, including additional maize, oil, and beans. Maternal supplement
consumption and sharing is measured during follow-up visits.
Discussion
The formative research allowed us to rapidly identify and modify aspects of the clinical trial
protocol in response to local attitudes, concerns, and circumstances, and it helped us to
determine important additional areas of inquiry. Concerns about the quality of local weaning
diets, and the impact of early breastfeeding cessation and infant malnutrition and health
were highlighted and quantified in this research. Although WHO recommends early
breastfeeding cessation for HIV-positive mothers, there is little guidance available on safe
infant feeding once breastfeeding ends. To reduce the risk of malnutrition and non-HIV
related morbidity and mortality that inevitably would result from early cessation of
breastfeeding, we modified our protocol to include the provision of a locally produced
ready-to-use food for replacement feeding until the child is 1 year of age [21]. Because the
cultural norm in Malawi is to gradually wean infants from breast milk, we found resistance
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to rapid breastfeeding cessation to be very strong. In response, we modified the protocol to
recommend cessation starting at 6 months of age, with the complete cessation by 7 months
of age. Cessation over a 1-month period adds a small risk of HIV-transmission,
approximately 0.0028% per day of breastfeeding, on average, accordingly to a study in
Kenya [22]. The protocol for maternal and infant ARV prophylaxis and maternal nutrition
supplementation were therefore modified accordingly so that these interventions are
continued to 7 months of age. Moreover, the infant feeding counseling and support provided
to study mothers were intensified to facilitate understanding and adoption of new feeding
practices. To respond to participants’ concerns about the amount of blood to be drawn from
mothers and infants, the amount was reduced to a quantity that was suitable to mothers but
still adequate for laboratory analyses.
We also discovered that our ability to obtain a meaningful informed consent from study
participants would be difficult. It was very clear that HIV-positive mothers and the broader
community did not recognize the experimental nature of medical research, and mothers did
not fully understand the antiretroviral intervention. For these reasons, we designed and
carried out additional formative research and a small intervention trial on informed consent
to learn how to better explain medical research and the purpose of the BAN study. Results
from these studies will be published elsewhere.
In summary, using rapid formative research methods, we were able to collect and analyze
qualitative data to inform the clinical trial protocol within three months. The formative
research did not prolong completion of the protocol, and approximately 5% of the clinical
trial year 1 budget was used. We believe the modifications and additions made to the
protocol on the basis of the formative research findings not only improved the design of the
research and safeguarded the health of study participants, but will also increase the
acceptance of the research within the community, especially among trial participants. We
identified areas in the protocol that had to be modified to achieve cultural sensitivity and
acceptability while maintaining study objectives. We also incorporated new interventions to
minimize any unplanned negative impact of our study on infants’ nutritional health and
conducted additional research to maximize understanding of the research during the
informed consent process. Without the formative research, we would have been unaware of
the significant issues that would have jeopardized the implementation of this research. We
encourage researchers who conduct clinical trials to incorporate formative research into the
protocol design to ensure participant understanding of the research, to safeguard
participants, and to increase feasibility and acceptance of the clinical research among
participants and in the community.
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Table 1
Study sample, methods, topics explored, and number of participants
Sample Method Topics Number of participants
HIV-positive mothers of infants less
than 1 year old (women participated
in up to three separate interviews)
In-depth interview Study participation issues, including
• Willingness to participate in
prevention research on mother-




• Adherence to drug and nutrition
interventions
23
In-depth interview Infant nutrition issues, including
• Current feeding practices
• Infant feeding by HIV-positive
mothers
27
In-depth interview Maternal nutrition issues, including
• Body image




Mothers of undisclosed HIV status
of infants less than 1 year old
(women participated in three
separate interviews)
Home visit interviews • 24-hour dietary recall for
mothers and infants
• Observation of hygiene and
sanitation conditions
• Taste testing of maternal
nutrition supplements
35
Mothers of undisclosed HIV status
of infants less than 1 year old
Home visit interviews Additional taste testing of maternal nutrition
supplements
17
Pregnant women Focus group discussion • Study participation issues
• Infant feeding by HIV-positive
mothers
• Social stigma and HIV
4 groups total; 25
participants
Grandmothers of grandchildren less
than 1 year old
Focus group discussion 4 groups total; 26
participants
Fathers who have infants less than 1
year old
Focus group discussion 4 groups total; 26
participants
Health providers In-depth interview • General questions on HIV and
MTCT
• Counseling practices for infant
and maternal nutrition
• Study participation issues
19
Traditional birth attendants In-depth interview • General questions on HIV and
MTCT
• Counseling practices for infant
nutrition
• Case load and management
7
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Sample Method Topics Number of participants
Community leaders In-depth interview • General questions on HIV and
MTCT
• Study participation issues
7
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